Phase II treatment of adults with brain metastases with Temodar [temozolomide]
Phase of Trial: Phase II
Latest Information Update: 20 Oct 2009
At a glance
- Drugs Temozolomide (Primary)
- Indications Cancer metastases
- Focus Therapeutic Use
- 20 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Oct 2009 Actual end date (Jun 2003) added as reported by ClinicalTrials.gov.
- 24 Sep 2005 New trial record.